The London Stock Exchange is set to lose another listing as Alliance Pharma agrees to a £349.7 million ($427 million) all-cash takeover by DBAY Advisors and Edmond de Rothschild’s ERES IV fund. Shareholders will receive 62.5 pence per share, a 41% premium over the last closing price. Alliance, listed on AIM since 2003, has been undergoing a strategic review and aims to implement new initiatives away from the public market to enhance its long-term prospects.
about Alliance Pharma to be Acquired in 427 Million Dollar Takeover DealAriane de Rothschild
0 posts last weekEdmond de Rothschild appoints Monika Vicandi as Chief Risk Officer
Edmond de Rothschild has appointed Monika Vicandi as the new Chief Risk, Legal & Compliance Officer, effective March 1, 2025. With over 20 years of experience in financial institutions, she will replace retiring Jean-Christophe Pernollet. CEO Ariane de Rothschild highlighted Vicandi’s international expertise as a significant asset for the bank’s development.
about Edmond de Rothschild appoints Monika Vicandi as Chief Risk Officer